Select a Region

North America

Newscenter

Browsing Archive: HEORHEOR | EVERSANA

Posted on 3月 27, 20243/27/24

Growing EVERSANA’s Value & Evidence Global Footprint with the Additions of Monique Martin, Pamela Vo and Deepika Thakur

Posted on 3月 27, 20243/27/24

Unlocking Insights: EVERSANA’s Value & Evidence Team’s Impact on Economic and Healthcare Resource Utilization Outcomes in Robotic vs. Manual Total Knee Arthroplasty

Posted on 2月 14, 20242/14/24

Excel in Market Access Success: Key Considerations for Leveraging Your Evidence

Posted on 1月 30, 20241/30/24

Empowering Success: EVERSANA’s Value & Evidence Team Guides Clients Through CMS Drug Negotiations Under the Inflation Reduction Act

Posted on 1月 22, 20241/22/24

Uncovering Health Disparities: Exploring Social Determinants of Metastatic Prostate Cancer Survival

Posted on 1月 22, 20241/22/24

EVERSANA’s High-Quality HEOR Methods Recognized in Published Independent Review

Posted on 1月 15, 20241/15/24

HemGenix Shines in Collaborative ITC Analysis: EVERSANA and CSL Behring Propel Gene Therapy to the Forefront in Hemophilia B Treatment

Posted on 8月 25, 20238/25/23

Unlocking Global Success: The Crucial Role of Integrated HEOR Programs in New Product Launches

Posted on 5月 16, 20235/16/23

Critical Success Factors for Launching Products with Fast Track, PRIME, or ILAP Designation

Posted on 4月 17, 20234/17/23

What EVERSANA’s Growing Abstract Count at ISPOR U.S. Means to the HEOR Industry

医療経済およびアウトカムリサーチ（HEOR）